Clinical Trial Update: Golimumab Dried Blood Spot Analysis [Phase 4]

View source ↗

Summary

Phase 4 trial update on golimumab examining dried blood spot analysis. The study targets Ulcerative Colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Simponi (golimumab)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Ulcerative Colitis | Phase 4 | Status: UNKNOWN